We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hemogenyx Pharmaceuticals Plc | LSE:HEMO | London | Ordinary Share | GB00BYX3WZ24 | ORD GBP0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.055 | 3.77% | 1.515 | 1.48 | 1.546 | 1.52 | 1.47 | 1.47 | 4,330,301 | 16:35:24 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 0 | -3.98M | -0.0035 | -4.34 | 17.36M |
Date | Subject | Author | Discuss |
---|---|---|---|
05/3/2018 08:33 | Tree shake and NT for all buying | ernestsyngen | |
05/3/2018 00:15 | Respect for that investment...I bet he’s looking for more than double digits:))) | moormoney | |
04/3/2018 23:54 | In antipation of tomorrow’s opening bell, I bet the person who laid 100,000 thousand down on last Thursday, will be watching closely! Follow the Big Money 💰💰 | gunwharf2 | |
04/3/2018 17:15 | Looking forward to tomorrow and the week ahead! Nice steady share price rise building on next week. That 10p will be smashed in March and then we are on to the teens! | ernestsyngen | |
04/3/2018 16:36 | It will happen the same to us. I can see a share price of double digits very soon | the patient investor | |
04/3/2018 16:32 | 28 Aug 2017 · Biotech giant Gilead Sciences is beefing up its cancer drug portfolio with a $11.9 billion deal to buy Kite Pharma, a company focused on a groundbreaking new class of treatments that turns the body's own immune cells into targeted blood cancer killers. | lufc5 | |
03/3/2018 09:26 | Hemo twitter account is a bit lively today- I’m expecting another BIG announcement next week! | gunwharf2 | |
02/3/2018 20:20 | Very nice Mike 🍺 | ernestsyngen | |
02/3/2018 17:32 | bought another 130k shares myself at 4.92p | 113mike | |
02/3/2018 16:35 | Decent size buy - 1630.40hrs ....270k shrs @5p. f | fillipe | |
02/3/2018 16:23 | Sunday Papers - Daily Mail is my guess. Hold on tight! | ernestsyngen | |
02/3/2018 16:19 | The weak sellers falling for the mm’s games. Big orders being filled here. If the sellers held tight this would be up 20% in minutes.....but no doubt they will panic sell into the mm’s hands! | cudmore | |
02/3/2018 16:13 | They are working with several major pharma's already since the breakthrough. That's rapid. | tidy 2 | |
02/3/2018 16:05 | As I stated before a big Pharma will pounce on these!!! Look at the two recent acquisitions across Europe! One was 400% up on the news!! | cudmore | |
02/3/2018 16:03 | Tuck away before close imho because next week I can see these soaring after the weekend press reports | cudmore | |
02/3/2018 16:02 | 99p material in my books | volsung | |
02/3/2018 15:57 | Nice little Sunday paper article is all it takes. Hold for the rush. | tidy 2 | |
02/3/2018 15:49 | Mystic Meg Zak should tell us what paper, he obviously has a scoop here | tsmith2 | |
02/3/2018 15:42 | GREAT STUFF ZAK! this is 10p material!! | the patient investor | |
02/3/2018 15:41 | Nice heads up from Zak. Sunday papers will cover HEMO's breakthrough treatment developements and humanised mice. | tidy 2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions